Transcriptional regulation of PDGF-a and TGF-β by + KTS WT1 deletion mutants and a mutant mimicking denys-drash syndrome

Renal Failure

Volumn 21, Issue 6, 1999, Pages 685-694

  Jin, Dong Kyu ^a,b   Kang, Soon Ja ^c   Kim, Sung Jin ^c   Bang, Eun Hee ^b   Hwang, Hye Zin ^b   Tadokoro, Keiko ^d   Yamada, Masao ^d   Kohsaka, Takao ^d  

^a Sungkyunkwan University   (South Korea)

^b Samsung Medical Center   (South Korea)

^c Ewha Womans University   (South Korea)

^d NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

Denys Drash syndrome; Transcription factor; Wilms tumor; WT1

Indexed keywords

PLATELET DERIVED GROWTH FACTOR A; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CASE REPORT; CHILD; CYTOKINE RELEASE; DENYS DRASH SYNDROME; GENE DELETION; GENE MUTATION; HUMAN; KIDNEY FAILURE; MALE; MISSENSE MUTATION; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROTEINURIA; SYNDROME; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

EID: 0344991644     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.3109/08860229909094162     Document Type: Article

References (27)

1. Call KM Glaser T, Ito CY Buckler AJ, Pelletier J, Haber DA, Rose EA, Kral A, Yeger K Lewis WH: Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms tumor locus. Cell 60:509-520, 1990.
2. Gessler M, Poustka A, Cavenee W, Neve RL, Orkin SH, Brims GA: Homozygous deletion in Wilms tumor of a zinc-finger gene identified by chromosome jumping. Nature 343:774-778, 1990.
3. Harber DA, Sohn RL, Buckler AJ, Pelletier J, Call KM, Housman DE: Alternative splicing and genomic structure of the Wilms tumor gene WT1. Proc Natl Acad Sci USA 88:9618-9622, 1991.
4. Bardeesy N, Falkoff D, Petruzzi MJ. Nowak N, Zabel B, Adam M, Aguiar MC, Grundy P, Show T, Pelletier J: Anaplastic Wilms tumor, a subtype displaying poor prognosis, harbors p53 gene mutations. Nat Genet7:91-97, 1994.
5. Hastie ND: Dominant negative mutations in Wilms tumor (WT1) gene cause Denys-Drash syndrome-proof that a tumor-suppressor gene plays a crucial role in normal genitourinary development. Hum Mol Genet 1:293-295, 1992.
6. Jadresic L, Leake J, Gordon I, Dillion MJ, Grant DB, Pritchand J, Risdon RA, Barratt TM: Clinicopathologic review of twelve children with nephropathy, Wilms tumor and geni'tal abnormalities (Drash syndrome). J Pediatr 117:117-725, 1990.
7. Kreidberg JA, Sariola H, Loring JM, Maeda M, Pelletier J, Housman D, Jaenisch R: WT1 is required for early kidney development. Cell 74:679-691, 1993.
8. Frasier S. Bashore RA, Mosier HD: Gonadoblastoma associated with pure gonadal dysgenesis in monozygotic twins. J Pediatr 64:740-745, 1964.
9. Kinberg JA, Angle CR, Wilson RB: Nephropathy-gonadal dysgenesis , type 2: renal failure in three siblings with XY dysgenesis in one. Am J Kidney Dis 9:501-510, 1987.
10. Barbaux S, Niaudet P, Gubler MC, Grunfeld JP, Jaubert F, Kuttennn F, Fekete CN. SouleyreauTherville N, Thibaud E, Fellous M, McElreavey K: Donor splice-site mutations in WT1 are responsible for Framer syndrome. Nat Genet 17:467-470. 1997.
11. Eccles MR, Grubb G, Ogawa O, Szeto I. Reeve AE: Cloning of novel Wilms tumor gene (WT1) cDNAs, evidence for antisense transcription of WT1. Oncogene 9:2059-2063, 1994.
12. Sukhatme VP: Early transcriptional events in cell growth the Egr family. J Am Soc Nephrol 1:859-866. 1990.
13. Madden SL, Cook DM, Moms JF, Gashler A, Sukhatme VP, Rauscher FJ III: Transcriptional repression mediated by the WT1 Wilms tumor gene product. Science 253:1550-1553, 1991.
14. Rupprech HD, Drummond IA, Madden SL, Rauscher FJ III, Sukhatme VP: The Wilms tumor suppressor gene WT1 is negatively autoregulated. J Biol Chem 269:6198-6206, 1994.
15. Johnson RJ, Raines EW, Floege J, Yoshimura A, Pritl P, Alpers C, Ross R: Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephrrtis in the rat by antibody to platelet-derived growth factor. J Exp Med 175:1413-1416, 1992.
16. Gesualdo L, Pinzani M, Floriano JJ, Hassan MO, Nagy NU, Schena FP, Emancipator SN, Abboud ME: Platelet-derived growth factor expression in mesangial proliferative glomerulonephritis. Lab Invest 65:160-167, 1991.
17. Border WA, Okuda S, Languino LR, Sporn MB, Ruoslahti E: Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1. Nature 346:371-374, 1990.
18. Gashler AL, Bonthron DT, Madden SL, Rauseher FJ III, Colins T, Sukhatme VP: Human platelet-derived growth factor: A chain is transcriptionally repressed by the Wilms tumor suppressor WT1. Proc Natl Acad Sci USA 89:10984-10988, 1992.
19. Dey BR, Sukhatme VP, Roberts AB, Sporn MB, Rauscher FJ III, Kim SJ: Repression of the transforming growth factor-β1 gene by the Wilms tumor suppressor WT1 gene product. Mol Endocrinol 8:595-602, 1994.
20. Clarkson PA, Davies HR, Williams DM, Chaudhary R, Hughes IA, Patterson MN: Mutational screening of the Wilms tumor gene, WT1 in males with genital abnormalities. J Med Genet 30:767-772, 1993.
21. Van Heyningen V: Sugar and spice and all things splice? Nat Genet. 17:367-368, 1997.
22. Kathryn P, Fleming S, Davidson D, Bickmore W, Porteus D, Gosden C, Bard J, Buckler A, Pelletier J, Housman D, van Heyningen V, Hastle N: The candidate Wilms tumor gene is involved in genitourinary development. Nature 346:194-197, 1990.
23. Wang Z, Qui Q, Huang J, Gurrier, Deuel TF: Products of alternatively spliced transcripts of the Wilms tumor suppressor gene, WT1, have altered DNA binding specificity and regulate transcription in different ways. Oncogene 10:415-422, 1995.
24. Menke AL, Shvarts A, Riteco N, van Ham RC, van der Eb, AJ, Jochemsen AG: Wilms tumor 1-KTS isoforms induce p53-independent apoptosis that can be partially rescued by expression of the epidermal growth factor receptor or the insulin receptor. Cancer Res 57:1353-1363, 1997.
25. Ye Y, Raychaudhuri B, Gumey A, Campbell CE, Williams BR: Regulation of WT1 by phosphorylation inhibition of DNA binding, alteration of transcriptional activity and cellular translocation. EMBO 15:5606-5615, 1996.
26. Fraizer GC, Wu YJ, Hewitt SM, Maity T, Ton CC, Huff V, Saunders GF: Transenptional regulation of the human Wilms tumor gene (WT1). Cell type-specific enhancer and promiscuous promoter. J Biol Chem 269:8892-8900, 1994.
27. Borel F, Barilla KC, Hamilton TB, Iskandar M, Romaniuk PJ: Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms tumor suppressor protein WT1. Biochem 37:12070-12076, 1996.